Source: https://www.frontiersin.org/articles/10.3389/fneur.2013.00130/full
Honokiol has shown potential neuroprotective effects through various mechanisms. Some of the ways in which honokiol promotes neuroprotection include:
- Preservation of Na+/K+ ATPase: Honokiol has been found to preserve the activity of Na+/K+ ATPase, an enzyme involved in maintaining the electrochemical gradient across neuronal cell membranes. This preservation helps maintain normal cellular function and protects against neuronal damage.
- Phosphorylation of pro-survival factors: Honokiol has been shown to promote the phosphorylation of pro-survival factors in neuronal cells. Phosphorylation of these factors is important for cell survival and protection against damage.
- Preservation of mitochondria: Honokiol has been found to protect mitochondria, the energy-producing organelles in cells. Preserving mitochondrial function is crucial for neuronal health and can prevent cell death.
- Modulation of GABAA: Honokiol has been shown to modulate GABAA receptors, which are involved in inhibitory neurotransmission in the brain. By modulating GABAA receptors, honokiol can have anxiolytic effects and promote relaxation.
- Prevention of glucose, ROS, and inflammatory-mediated damage: Honokiol has been found to protect against damage caused by glucose, reactive oxygen species (ROS), and inflammatory processes in the brain. By preventing or reducing these damaging factors, honokiol promotes neuroprotection.
In preclinical studies, honokiol has demonstrated neuroprotective effects in various conditions. It has been shown to mitigate the impact of stroke and seizure, improve learning and memory performance, and protect against neurotoxicity.
In the context of stroke, honokiol has been administered intravenously before or after ischemia (lack of blood flow to the brain). It has been found to reduce the volume of infarction (tissue damage caused by ischemia) and protect against neuronal damage.
In the case of seizure disorders, honokiol has been shown to ameliorate the neurotoxic effects of seizures induced by NMDA (N-methyl-D-aspartate) in animal models. It has demonstrated a more potent seizure threshold-increasing effect compared to other compounds.
Honokiol has also been investigated for its potential role in promoting cognitive health. It has been found to prevent age-related memory and learning deficits in animal models by preserving cholinergic neurons and enhancing pro-survival pathways. Additionally, honokiol has shown neuroprotective effects against β-amyloid-induced neuronal death, a hallmark of Alzheimer’s disease.
Furthermore, honokiol has demonstrated anxiolytic effects and has been evaluated for its potential in promoting sleep. It has been found to block glutamate and NMDA receptors, which are involved in excitatory neurotransmission, thus contributing to its calming and sleep-promoting properties.
It is important to note that while pre-clinical studies have shown promising results, further research is needed to determine the full extent of honokiol’s neuroprotective effects and its potential therapeutic applications in humans.
